Immunome, Inc.
IMNM
$20.98
$0.271.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.72% | 13.54% | -3.71% | 2.46% | 57.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 80.75% | 86.32% | 58.42% | 60.41% | -38.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 198.54% | 14.70% | -2.41% | 3.13% | 52.96% |
|
|
|||||
| Total Current Assets | 198.54% | 14.70% | -2.41% | 3.13% | 52.96% |
| Net Property, Plant & Equipment | 22.40% | 53.64% | 65.84% | 162.43% | 295.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.34% | 44.48% | 37.80% | 565.72% | 2,155.50% |
| Total Assets | 184.38% | 16.54% | 0.03% | 7.17% | 61.73% |
|
|
|||||
| Total Accounts Payable | -76.47% | 74.73% | -33.87% | 27.12% | 328.54% |
| Total Accrued Expenses | 51.28% | -6.09% | -11.17% | 58.59% | 259.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -79.68% |
| Total Finance Division Other Current Liabilities | -75.70% | -83.67% | -91.23% | -59.18% | 32.91% |
| Total Other Current Liabilities | -75.70% | -83.67% | -91.23% | -59.18% | 32.91% |
| Total Current Liabilities | -17.16% | -20.45% | -42.66% | 0.09% | 148.78% |
|
|
|||||
| Total Current Liabilities | -17.16% | -20.45% | -42.66% | 0.09% | 148.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.17% | 62.87% | 67.22% | 295.52% | 255.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -17.32% | -15.56% | -36.24% | 4.05% | 106.14% |
|
|
|||||
| Common Stock & APIC | 95.52% | 41.80% | 35.48% | 35.54% | 103.37% |
| Retained Earnings | -41.18% | -51.14% | -54.68% | -58.22% | -131.49% |
| Treasury Stock & Other | -- | -- | -1,300.00% | -175.00% | 159.09% |
| Total Common Equity | 250.15% | 22.81% | 6.08% | 7.55% | 51.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 250.15% | 22.81% | 6.08% | 7.55% | 51.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 250.15% | 22.81% | 6.08% | 7.55% | 51.12% |
|
|
|||||